+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Sanofi S.A. - Enterprise Tech Ecosystem Series

  • PDF Icon

    Company Profile

  • 24 Pages
  • November 2021
  • GlobalData
  • Sanofi S.A.
  • ID: 5505183
Sanofi S.A. (Sanofi) is a France-based multinational life sciences company. It focuses on the research & development, manufacture, and marketing of a wide range of medicines and vaccines. Its product portfolio includes over-the-counter medicines for cough, cold, allergy, gastro-intestinal disorders, and pain; therapeutic solutions for diabetes and cardiovascular diseases; therapies for rare diseases, neurology, cancer, immunology and rare blood disorders; and vaccines for protection against various bacterial and viral diseases. Sanofi has launched technology accelerator programs and innovation labs to develop digital healthcare solutions in partnership with start-ups. The company partnered with technology companies, universities and research institutes to accelerate drug discovery and development, develop better drugs, offer digital healthcare services to patients and improve operations.

This report provides insight into Sanofi's technology activities, including -
  • Insights of its digital transformation strategies and accelerator & innovation programs
  • Overview of technology initiatives covering partnerships, product launches and investments
  • Insights on each technology initiative including technology theme, objective, and benefits
  • Details of estimated ICT budgets and major ICT contracts

Scope

  • Sanofi is strengthening its focus on the use of innovative technologies to enhance its digital banking capabilities. AI, cloud, big data, virtual and augmented reality, connected care and robotics are among the technologies the pharmaceutical company is focusing on. The company intends to enhance digital marketing and healthcare consultation, scale e-commerce for vaccines, use data to accelerate R&D, improve patient experience on digital channels such as mobile apps and improve employee experiences through digital technologies.

Reasons to Buy

  • Gain insights into Sanofi's technology operations.
  • Gain insights into its technology strategies and innovation initiatives.
  • Gain insights into its technology themes under focus.
  • Gain insights into its various product launches, partnerships and investments.

Table of Contents

  • Overview
  • Digital Transformation Strategy
  • Accelerators, Incubators, & Other Innovation Programs
  • Technology Focus
  • Technology Initiatives
  • Venture Arm
  • Investments
  • Partnership & Investment Network Map
  • ICT Budgets & Contracts
  • Key Executives
  • About The Publisher

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Omada Health
  • Click Therapeutics
  • Aetion
  • Evidation
  • Medisafe
  • Clip Health
  • Vizibl
  • Gyenno
  • Abbott
  • HakoBio
  • TriNetX
  • MDConnect
  • TrialSpark
  • Cegedim SA
  • Health2Sync
  • Researchably
  • Atman
  • Google
  • Voxly Digital
  • Happify
  • Babylon
  • Capgemini
  • Ypso-Facto
  • CentraleSupélec
  • CytoReason